News

Traditional fingerstick screening for glucose and lipids is proving inadequate when identifying near-term ...

CardioDx Inc. is a molecular diagnostics company specializing in cardiovascular genomics. It...

A new “fluid biopsy” technique that could identify patients at high risk of a heart attack by...

ACC, iPad cardiology apps

DAIC readers chose the following stories as the most popular content in 2013, based on website analytics.

Combining genetic data with clinical information to determine the initial dosage of the blood thinner warfarin, used to prevent blood clots in the circulatory system, was no more effective in...

antiplatelet therapy clinical trial blood test platelet function corgenix

study conducted in Ireland found that aspirin does not adequately protect 20 percent of patients with...

PDI, Inc. and Transgenomic, Inc. announced the signing of a U.S. collaboration agreement to commercialize CardioPredict, a molecular diagnostic test developed by Transgenomic. CardioPredict is a...

blood testing cardiodx corus cad coronary artery disease

CardioDx Inc. announced results of two studies indicating that Corus CAD, a ...

blood tests heart failure treatments cardiac rehabilitation critical diagnostics

Critical Diagnostics announced that results of the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise (HF-Action) ...

blood testing cath lab beckman coulter danaher

Delivering the precision, clinical sensitivity and clinical specificity necessary to assist physicians with the diagnosis of myocardial infarction (MI), Beckman Coulter Inc. announced the U.S...

Loyola, Loyola Health, Loyola Medical Center

Researchers have determined that fingerstick cardiac troponin I assay testing using the point-of-care i-STAT device is not accurate enough to determine the exact troponin level without the...

Aggredyne Inc., has received ISO 13485 certification for its quality control program related to the manufacture of the AggreGuide family of platelet function analyzers.

Atherotech Diagnostics Lab has added three new genetic tests to its cardiometabolic test offering: warfarin sensitivity, Plavix sensitivity and the thrombophilia risk test.

 

Abbott promised preliminary results from a study presented at the ESC Congress 2013, suggesting that its high sensitive troponin test may help doctors improve the diagnosis and prognosis of...

Abbott announced results from a study evaluating its High Sensitive Troponin-I (hsTnI) assay. The study, conducted by researchers at Brigham and Women's Hospital, demonstrated that ...

Polymer Technology Systems Inc. has introduced the CardioChek Plus analyzer. It is a combination reflectance lipid and electrochemical glucose analyzer that delivers rapid test results for lipids...

T2 Biosystems announced the presentation of data strongly correlating T2Hemostat results with patients’ clinical outcomes. In 26 patients who presented with chest pain and underwent cardiac...

Clinical Study Aspirin Duke Medicine Blood Test Platelet Functioning Testing

Aspirin has been widely used for more than 50 years as a common, inexpensive blood thinner for patients with heart disease and stroke, but doctors have little understanding of how it works and why...

University of Maryland Medical Center Genetic-Testing Program Cardiac Stent

Patients with coronary artery disease who undergo treatment at the University of Maryland Medical Center (UMMC) now can receive long-term therapy based on information found in their genes. As part...